![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 15319 |
FusionGeneSummary for GPX3_EIF2AK2 |
![]() |
Fusion gene information | Fusion gene name: GPX3_EIF2AK2 | Fusion gene ID: 15319 | Hgene | Tgene | Gene symbol | GPX3 | EIF2AK2 | Gene ID | 2878 | 5610 |
Gene name | glutathione peroxidase 3 | eukaryotic translation initiation factor 2 alpha kinase 2 | |
Synonyms | GPx-P|GSHPx-3|GSHPx-P | EIF2AK1|PKR|PPP1R83|PRKR | |
Cytomap | 5q33.1 | 2p22.2 | |
Type of gene | protein-coding | protein-coding | |
Description | glutathione peroxidase 3GPx-3extracellular glutathione peroxidaseglutathione peroxidase 3 (plasma)plasma glutathione peroxidase | interferon-induced, double-stranded RNA-activated protein kinaseP1/eIF-2A protein kinasedouble stranded RNA activated protein kinaseeIF-2A protein kinase 2interferon-inducible elF2alpha kinasep68 kinaseprotein kinase Rprotein kinase, interferon-ind | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P22352 | P19525 | |
Ensembl transtripts involved in fusion gene | ENST00000388825, ENST00000521722, ENST00000517973, | ENST00000233057, ENST00000395127, ENST00000405334, | |
Fusion gene scores | * DoF score | 8 X 11 X 3=264 | 34 X 1 X 15=510 |
# samples | 14 | 34 | |
** MAII score | log2(14/264*10)=-0.915111102413487 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(34/510*10)=-0.584962500721156 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: GPX3 [Title/Abstract] AND EIF2AK2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | GPX3 | GO:0051289 | protein homotetramerization | 3693360 |
Tgene | EIF2AK2 | GO:0006468 | protein phosphorylation | 19189853 |
Tgene | EIF2AK2 | GO:0017148 | negative regulation of translation | 12882984 |
Tgene | EIF2AK2 | GO:0035455 | response to interferon-alpha | 19840259 |
Tgene | EIF2AK2 | GO:0046777 | protein autophosphorylation | 22801494 |
Tgene | EIF2AK2 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity | 15121867 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | KIRP | TCGA-5P-A9KC-01A | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-intron | ENST00000388825 | ENST00000233057 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
5CDS-intron | ENST00000388825 | ENST00000395127 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
5CDS-intron | ENST00000388825 | ENST00000405334 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000521722 | ENST00000233057 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000521722 | ENST00000395127 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000521722 | ENST00000405334 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000517973 | ENST00000233057 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000517973 | ENST00000395127 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
intron-intron | ENST00000517973 | ENST00000405334 | GPX3 | chr5 | 150408554 | + | EIF2AK2 | chr2 | 37342384 | - |
Top |
FusionProtFeatures for GPX3_EIF2AK2 |
![]() |
Hgene | Tgene |
GPX3 | EIF2AK2 |
Protects cells and enzymes from oxidative damage, bycatalyzing the reduction of hydrogen peroxide, lipid peroxides andorganic hydroperoxide, by glutathione. | IFN-induced dsRNA-dependent serine/threonine-proteinkinase which plays a key role in the innate immune response toviral infection and is also involved in the regulation of signaltransduction, apoptosis, cell proliferation and differentiation.Exerts its antiviral activity on a wide range of DNA and RNAviruses including hepatitis C virus (HCV), hepatitis B virus(HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1).Inhibits viral replication via phosphorylation of the alphasubunit of eukaryotic initiation factor 2 (EIF2S1), thisphosphorylation impairs the recycling of EIF2S1 between successiverounds of initiation leading to inhibition of translation whicheventually results in shutdown of cellular and viral proteinsynthesis. Also phosphorylates other substrates includingp53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral proteinUS11. In addition to serine/threonine-protein kinase activity,also has tyrosine-protein kinase activity and phosphorylates CDK1at 'Tyr-4' upon DNA damage, facilitating its ubiquitination andproteosomal degradation. Either as an adapter protein and/or viaits kinase activity, can regulate various signaling pathways (p38MAP kinase, NF-kappa-B and insulin signaling pathways) andtranscription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved inthe expression of genes encoding proinflammatory cytokines andIFNs. Activates the NF-kappa-B pathway via interaction with IKBKBand TRAF family of proteins and activates the p38 MAP kinasepathway via interaction with MAP2K6. Can act as both a positiveand negative regulator of the insulin signaling pathway (ISP).Negatively regulates ISP by inducing the inhibitoryphosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5Awhich activates FOXO1, which in turn up-regulates the expressionof insulin receptor substrate 2 (IRS2). Can regulate NLRP3inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 andNLRC4 inflammasomes. Can trigger apoptosis via FADD-mediatedactivation of CASP8. Plays a role in the regulation of thecytoskeleton by binding to gelsolin (GSN), sequestering theprotein in an inactive conformation away from actin.{ECO:0000269|PubMed:10848580, ECO:0000269|PubMed:11836380,ECO:0000269|PubMed:15121867, ECO:0000269|PubMed:15229216,ECO:0000269|PubMed:18835251, ECO:0000269|PubMed:19189853,ECO:0000269|PubMed:19229320, ECO:0000269|PubMed:19507191,ECO:0000269|PubMed:19840259, ECO:0000269|PubMed:20171114,ECO:0000269|PubMed:20395957, ECO:0000269|PubMed:20685959,ECO:0000269|PubMed:21072047, ECO:0000269|PubMed:21123651,ECO:0000269|PubMed:21710204, ECO:0000269|PubMed:22214662,ECO:0000269|PubMed:22381929, ECO:0000269|PubMed:22801494,ECO:0000269|PubMed:22948139, ECO:0000269|PubMed:23084476,ECO:0000269|PubMed:23115276, ECO:0000269|PubMed:23229543,ECO:0000269|PubMed:23372823, ECO:0000269|PubMed:23399035}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for GPX3_EIF2AK2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for GPX3_EIF2AK2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
GPX3 | GPX3, UBQLN1, TP53I3 | EIF2AK2 | DBNL, FANCC, PRKRIP1, STAT1, PPP1CA, PRKRA, TP53, ILF3, METAP2, DNAJC3, PPP2R5A, ILF2, EIF2AK2, TARBP2, MAP3K5, CHUK, IKBKB, HIST2H2AC, PDGFRB, STAT3, EIF2S1, DHX58, CCNA2, DHX9, DICER1, EDC4, STAU2, ZNF346, STAU1, CCDC124, CDK3, EBNA1BP2, FARSB, FTSJ3, GLTSCR2, IFRD1, NOC3L, PPP1CC, DHX30, EIF6, FARSA, GNL3, GTPBP4, HIST1H1C, HNRNPC, HNRNPCL1, KCTD17, LYAR, MOV10, NOP2, PABPC4, PURA, SSB, TOLLIP, TOP1, XRN2, MAVS, HDGF, ELAVL1, MAP3K7, ISG15, CUL3, CAND1, ATP6V1F, JAK1, TYK2, HSP90AA1, IL7R, NPM1, EIF2A, PTGES3, HECW2, IGF2BP3, IGF2BP2, EGFR, TRAF5, TRAF6, TRAF2, CYP1A1, NTRK1, IFI16, SCARB2, RPL10, ELMSAN1, CDCA5, CHMP4B, MACROD1, MCM2, CDC37, PRKRIR, HIST1H2AB, MECP2, GPX7, IQCF1, PTEN, RPL6, RPLP0, RPS2, RPS3A, LMNA, COX15, DLD, DLST |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for GPX3_EIF2AK2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Hgene | GPX3 | P22352 | DB00143 | Glutathione | Glutathione peroxidase 3 | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for GPX3_EIF2AK2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | GPX3 | C0014175 | Endometriosis | 2 | CTD_human |
Hgene | GPX3 | C0024121 | Lung Neoplasms | 2 | CTD_human |
Hgene | GPX3 | C0028754 | Obesity | 2 | CTD_human |
Hgene | GPX3 | C0001418 | Adenocarcinoma | 1 | CTD_human |
Hgene | GPX3 | C0015624 | Fanconi Syndrome | 1 | CTD_human |
Hgene | GPX3 | C0021655 | Insulin Resistance | 1 | CTD_human |
Hgene | GPX3 | C0023903 | Liver neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Hgene | GPX3 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |
Tgene | EIF2AK2 | C0021400 | Influenza | 1 | CTD_human |
Tgene | EIF2AK2 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | EIF2AK2 | C0038220 | Status Epilepticus | 1 | CTD_human |